JOSD1: A Protein with Potential Therapeutic Applications (G9929)

Target Name: JOSD1

NCBI ID: G9929

JOSD1

JOSD1: A Protein with Potential Therapeutic Applications

The Josephin Domain-Containing Protein 1 (JOSD1) is a protein that is expressed in various tissues and cells throughout the body. It is a member of the superfamily of JARID proteins, which are known for their role in intracellular signaling. JOSD1 is unique due to its ability to interact with and modulate the activity of the protein tyrosine phosphatase (PTP) kinase, which is a key enzyme involved in the regulation of protein kinase activity.

JOSD1 is a 21-kDa protein that is expressed in a variety of tissues, including muscle, heart, kidney, and brain. It is highly conserved, with a calculated pI of 4.8 and a predicted localization in the cytoplasm. JOSD1 is associated with the endoplasmic reticulum (ER), where it can interact with and modulate the activity of PTP kinase.

JOSD1 has been shown to play a role in intracellular signaling by regulating the activity of PTP kinase. Studies have shown that JOSD1 can inhibit the activity of PTP kinase by binding to PTP, thereby inhibiting the signal transduction pathway. In addition, JOSD1 can also interact with proteins such as PD-L1 and PD-L2, thereby affecting the progression of immunogenic diseases.

The role of JOSD1 in tumors also deserves attention. Studies have shown that the expression level of JOSD1 is positively correlated with the prognosis of various tumors, including lung cancer, breast cancer, and ovarian cancer. In addition, the expression level of JOSD1 is also positively correlated with tumor invasion and metastasis. Therefore, JOSD1 may be a potential tumor target.

JOSD1 also has promising applications in drug screening and biomarker research. For example, JOSD1 can be used as a biomarker for PD-L1-positive tumors to evaluate patient prognosis and treatment response. In addition, JOSD1 can also be used as a biomarker of muscle damage and cellular stress to evaluate patient recovery.

In short, JOSD1 is a protein with important biological significance and clinical application prospects. In the future, with the continuous advancement of technology, the research on JOSD1 will be more in-depth and provide people with better treatments and biomarkers.

Protein Name: Josephin Domain Containing 1

Functions: Deubiquitinates monoubiquitinated probes (in vitro). When ubiquitinated, cleaves 'Lys-63'-linked and 'Lys-48'-linked poly-ubiquitin chains (in vitro), hence may act as a deubiquitinating enzyme. May increase macropinocytosis and suppress clathrin- and caveolae-mediated endocytosis. May enhance membrane dynamics and cell motility independently of its catalytic activity

The "JOSD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about JOSD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets